NEGRI, AIDE
 Distribuzione geografica
Continente #
NA - Nord America 157
EU - Europa 150
AS - Asia 58
OC - Oceania 1
Totale 366
Nazione #
US - Stati Uniti d'America 153
IT - Italia 75
CN - Cina 31
IE - Irlanda 27
SE - Svezia 25
SG - Singapore 21
DE - Germania 5
FR - Francia 5
CA - Canada 4
TR - Turchia 4
FI - Finlandia 3
BE - Belgio 2
CZ - Repubblica Ceca 2
GB - Regno Unito 2
AU - Australia 1
AZ - Azerbaigian 1
CH - Svizzera 1
LT - Lituania 1
NL - Olanda 1
NP - Nepal 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 366
Città #
Ann Arbor 38
Chandler 30
Parma 24
Dublin 23
Singapore 18
Santa Clara 12
Ashburn 9
Boardman 7
Giugliano in Campania 5
Redmond 5
Ardea 4
Marseille 4
Milan 4
Valhalla 4
Beijing 3
Hefei 3
Helsinki 3
Princeton 3
Rome 3
Shanghai 3
Shenyang 3
Toronto 3
Brescia 2
Brussels 2
Carini 2
Dallas 2
Dearborn 2
Falls Church 2
Florence 2
Fremont 2
Izmir 2
Jinan 2
Kocaeli 2
Leawood 2
Ningbo 2
Taranto 2
Amsterdam 1
Andover 1
Avellino 1
Baku 1
Bari 1
Bratislava 1
Brno 1
Brooklyn 1
Canary Wharf 1
Correggio 1
Des Moines 1
Fuzhou 1
Grafing 1
Guangzhou 1
Haikou 1
Houston 1
Kathmandu 1
Kunming 1
London 1
Los Angeles 1
Menlo Park 1
Montreal 1
Nanchang 1
Nanjing 1
Norwalk 1
Palermo 1
Portici 1
Qingdao 1
San Giovanni in Fiore 1
Sydney 1
Tianjin 1
Washington 1
Wilmington 1
Zhengzhou 1
Zurich 1
Totale 274
Nome #
Clusterin Silencing in Prostate Cancer Induces Matrix Metalloproteinases by an NF-κB-Dependent Mechanism 145
Molecular targets of epigallocatechin—gallate (EGCG): A special focus on signal transduction and cancer 99
Simultaneous administration of EZH2 and BET inhibitors inhibits proliferation and clonogenic ability of metastatic prostate cancer cells 66
Inflammation, extracellular matrix remodeling, and proteostasis in tumor microenvironment 64
Totale 374
Categoria #
all - tutte 1.419
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.419


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202044 0 0 0 0 0 12 9 3 8 10 1 1
2020/202155 1 2 7 3 3 8 8 10 3 7 2 1
2021/202234 1 4 2 2 8 1 3 3 0 0 4 6
2022/2023114 5 12 11 10 6 11 0 12 27 3 9 8
2023/202435 5 4 2 0 5 4 2 1 1 4 4 3
2024/202577 4 7 4 17 21 24 0 0 0 0 0 0
Totale 374